Towercrest Capital Management Ishares Biotechnology ETF Transaction History

Towercrest Capital Management

$616 Million
Q2 2024

A detailed history of Towercrest Capital Management transactions in Ishares Biotechnology ETF stock. As of the latest transaction made, Towercrest Capital Management holds 9,163 shares of IBB stock, worth $1.33 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

9,163

Previous 14,613 37.3%

Holding current value

$1.33 Million

Previous $2.01 Million 37.31%

% of portfolio

0.2%

Previous 0.33%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$124.64 - $139.96 $679,288 - $762,782	-5,450 Reduced 37.3%	9,163 $1.26 Million
Q1 2024 May 09, 2024	SELL	$132.3 - $140.89 $661 - $704	-5 Reduced 0.03%	14,613 $2.01 Million
Q3 2023 Nov 13, 2023	SELL	$122.27 - $131.47 $398,600 - $428,592	-3,260 Reduced 18.23%	14,618 $1.79 Million
Q4 2022 Feb 09, 2023	SELL	$117.58 - $138.43 $50,206 - $59,109	-427 Reduced 2.33%	17,878 $2.35 Million
Q2 2021 Aug 13, 2021	BUY	$146.13 - $163.65 $538,781 - $603,377	3,687 Added 25.22%	18,305 $3 Million
Q2 2020 Aug 13, 2020	SELL	$103.79 - $138.65 $103,790 - $138,650	-1,000 Reduced 6.4%	14,618 $2 Million
Q1 2020 May 14, 2020	BUY	$94.39 - $123.48 $94,390 - $123,480	1,000 Added 6.84%	15,618 $1.68 Million
Q4 2019 Feb 14, 2020	SELL	$97.24 - $123.5 $48,620 - $61,750	-500 Reduced 3.31%	14,618 $1.76 Million
Q2 2019 Aug 14, 2019	SELL	N/A	-1,499 Reduced 9.02%	15,118 $1.65 Million
Q1 2019 May 15, 2019	SELL	N/A	-4,746 Reduced 22.22%	16,617 $1.86 Million
Q4 2018 Feb 15, 2019	BUY	N/A	6,500 Added 43.73%	21,363 $2.06 Million
Q3 2018 Nov 19, 2018	BUY	N/A	14,863 New	14,863 $1.81 Million

Others Institutions Holding IBB

# of Institutions

1,015

Shares Held

37.4M

Call Options Held

2.39M

Put Options Held

10.2M

View Full List

About ISHARES BIOTECHNOLOGY ETF

Ticker IBB
Sector ETFs
Industry ETFs

More about IBB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Towercrest Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Towercrest Capital Management with notifications on news.

Account

Towercrest Capital Management Ishares Biotechnology ETF Transaction History